[HTML][HTML] Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing …

M Kusumoto, M Jitsuiki, T Motegi, K Harada - International Journal of …, 2024 - mdpi.com
Flomoxef (FMX) may be a potential alternative to carbapenems for dogs infected with
Enterobacterales-producing extended-spectrum β-lactamase (ESBL-E). However, the …

Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales from …

M Kusumoto, M Jitsuiki, T Motegi… - International Journal of …, 2024 - europepmc.org
Flomoxef (FMX) may be a potential alternative to carbapenems for dogs infected with
Enterobacterales-producing extended-spectrum β-lactamase (ESBL-E). However, the …

Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales from …

M Kusumoto, M Jitsuiki, T Motegi… - … journal of molecular …, 2024 - pubmed.ncbi.nlm.nih.gov
Flomoxef (FMX) may be a potential alternative to carbapenems for dogs infected with
Enterobacterales-producing extended-spectrum β-lactamase (ESBL-E). However, the …

Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales from …

M Kusumoto, M Jitsuiki, T Motegi… - International Journal of …, 2024 - search.ebscohost.com
Flomoxef (FMX) may be a potential alternative to carbapenems for dogs infected with
Enterobacterales-producing extended-spectrum β-lactamase (ESBL-E). However, the …

Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales from …

M Kusumoto, M Jitsuiki, T Motegi… - International Journal of …, 2024 - go.gale.com
Flomoxef (FMX) may be a potential alternative to carbapenems for dogs infected with
Enterobacterales-producing extended-spectrum β-lactamase (ESBL-E). However, the …

Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales from …

M Kusumoto, M Jitsuiki, T Motegi… - International Journal of …, 2024 - search.proquest.com
Flomoxef (FMX) may be a potential alternative to carbapenems for dogs infected with
Enterobacterales-producing extended-spectrum β-lactamase (ESBL-E). However, the …

[HTML][HTML] Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing …

M Kusumoto, M Jitsuiki, T Motegi… - International Journal of …, 2024 - ncbi.nlm.nih.gov
Flomoxef (FMX) may be a potential alternative to carbapenems for dogs infected with
Enterobacterales-producing extended-spectrum β-lactamase (ESBL-E). However, the …

Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales from …

M Kusumoto, M Jitsuiki, T Motegi… - International Journal of …, 2024 - europepmc.org
Flomoxef (FMX) may be a potential alternative to carbapenems for dogs infected with
Enterobacterales-producing extended-spectrum β-lactamase (ESBL-E). However, the …